Abstract:ObjectiveTo develop a fully automated AI system to quantitatively assess the disease severity and disease progression of COVID-19 using thick-section chest CT images.MethodsIn this retrospective study, an AI system was developed to automatically segment and quantify the COVID-19-infected lung regions on thick-section chest CT images. Five hundred thirty-one CT scans from 204 COVID-19 patients were collected from one appointed COVID-19 hospital. The automatically segmented lung abnormalities were compared with manual segmentation of two experienced radiologists using the Dice coefficient on a randomly selected subset (30 CT scans). Two imaging biomarkers were automatically computed, i.e., the portion of infection (POI) and the average infection HU (iHU), to assess disease severity and disease progression. The assessments were compared with patient status of diagnosis reports and key phrases extracted from radiology reports using the area under the receiver operating characteristic curve (AUC) and Cohen’s kappa, respectively.ResultsThe dice coefficient between the segmentation of the AI system and two experienced radiologists for the COVID-19-infected lung abnormalities was 0.74 ± 0.28 and 0.76 ± 0.29, respectively, which were close to the inter-observer agreement (0.79 ± 0.25). The computed two imaging biomarkers can distinguish between the severe and non-severe stages with an AUC of 0.97 (p value < 0.001). Very good agreement (κ = 0.8220) between the AI system and the radiologists was achieved on evaluating the changes in infection volumes.ConclusionsA deep learning–based AI system built on the thick-section CT imaging can accurately quantify the COVID-19-associated lung abnormalities and assess the disease severity and its progressions.Key Points• A deep learning–based AI system was able to accurately segment the infected lung regions by COVID-19 using the thick-section CT scans (Dice coefficient ≥ 0.74).• The computed imaging biomarkers were able to distinguish between the non-severe and severe COVID-19 stages (area under the receiver operating characteristic curve 0.97).• The infection volume changes computed by the AI system were able to assess the COVID-19 progression (Cohen’s kappa 0.8220).

Automatic Quantification of Abnormal Lung Parenchymal Attenuation on Chest Computed Tomography Images Using Densitometry and Texture-based Analysis

Automated detection and quantification of COVID-19 airspace disease on chest radiographs: A novel approach achieving radiologist-level performance using a CNN trained on digital reconstructed radiographs (DRRs) from CT-based ground-truth

Classification and Quantification of Emphysema Using a Multi-Scale Residual Network

Development and Validation of a 3D-Convolutional Neural Network Model Based on Chest CT for Differentiating Active Pulmonary Tuberculosis from Community-Acquired Pneumonia

Deep learning automated quantification of lung disease in pulmonary hypertension on CT pulmonary angiography: A preliminary clinical study with external validation

Automatic Calcium Scoring in Low-Dose Chest CT Using Deep Neural Networks With Dilated Convolutions

Pre-Training Autoencoder for Lung Nodule Malignancy Assessment Using CT Images

Rapid quantification of COVID-19 pneumonia burden from computed tomography with convolutional long short-term memory networks

An Automated Method to Assess the Distribution of Low Attenuation Areas on Chest CT Scans in Chronic Pulmonary Emphysema Patients

Rapid quantification of COVID-19 pneumonia burden from computed tomography with convolutional LSTM networks

Quantification of Lung Abnormalities in Cystic Fibrosis using Deep Networks

Automatic lung segmentation in COVID-19 patients: Impact on quantitative computed tomography analysis

Automated Quantification of Pneumonia Infected Volume in Lung CT Images: A Comparison with Subjective Assessment of Radiologists

Automated assessment of disease severity of COVID-19 using artificial intelligence with synthetic chest CT

From community-acquired pneumonia to COVID-19: a deep learning–based method for quantitative analysis of COVID-19 on thick-section CT scans

CT image segmentation for inflamed and fibrotic lungs using a multi-resolution convolutional neural network

Improved Detection of Chronic Obstructive Pulmonary Disease at Chest CT Using the Mean Curvature of Isophotes

High Throughput Lung And Lobar Segmentation By 2d And 3d Cnn On Chest Ct With Diffuse Lung Disease

Optimizing Convolutional Neural Networks for Chronic Obstructive Pulmonary Disease Detection in Clinical Computed Tomography Imaging

Diagnostic accuracy of automated ACR BI-RADS breast density classification using deep convolutional neural networks

Identifying Suspicious Regions of Covid-19 by Abnormality-Sensitive Activation Mapping